Department of Biology, Faculty of Science, Hacettepe University, 06800, Ankara, Turkey.
Department of Biomedicine, Aarhus University, South, Bldg 1233, 3 Wilhelm Meyers Alle, 8000, Aarhus, Denmark.
Cell Mol Life Sci. 2020 Mar;77(5):953-962. doi: 10.1007/s00018-019-03219-w. Epub 2019 Jul 13.
The water channel aquaporin 2 (AQP2) is responsible for water reabsorption by kidney collecting duct cells. A substitution of amino acid leucine 137 to proline in AQP2 (AQP2-L137P) causes Nephrogenic Diabetes Insipidus (NDI). This study aimed to determine the cell biological consequences of this mutation on AQP2 function. Studies were performed in HEK293 and MDCK type I cells, transfected with wildtype (WT) AQP2 or an AQP2-L137P mutant. AQP2-L137P was predominantly detected as a high-mannose form of AQP2, whereas AQP2-WT was observed in both non-glycosylated and complex glycosylated forms. In contrast to AQP2-WT, the AQP2-L137P mutant did not accumulate on the apical plasma membrane following stimulation with forskolin. Ubiquitylation of AQP2-L137P was different from AQP2-WT, with predominance of non-distinct protein bands at various molecular weights. The AQP2-L137P mutant displayed reduced half-life compared to AQP2-WT. Treatment of cells with chloroquine increased abundance of AQP2-WT, but not AQP2-L137P. In contrast, treatment with MG132 increased abundance of AQP2-L137P but not AQP2-WT. Xenopus oocytes injected with AQP2-WT had increased osmotic water permeability when compared to AQP2-L137P, which correlated with lack of the mutant form in the plasma membrane. From the localization of the mutation and nature of the substitution it is likely that AQP2-L137P causes protein misfolding, which may be responsible for the observed functional defects. The data suggest that the L137P mutation results in altered AQP2 protein maturation, increased AQP2 degradation via the proteasomal pathway and limited plasma membrane expression. These combined mechanisms are likely responsible for the phenotype observed in this class of NDI patients.
水通道蛋白 aquaporin 2(AQP2)负责肾脏集合管细胞的水重吸收。AQP2 中氨基酸亮氨酸 137 被脯氨酸取代(AQP2-L137P)会导致肾性尿崩症(NDI)。本研究旨在确定该突变对 AQP2 功能的细胞生物学后果。在转染野生型(WT)AQP2 或 AQP2-L137P 突变体的 HEK293 和 MDCK Ⅰ型细胞中进行了研究。AQP2-L137P 主要以 AQP2 的高甘露糖形式检测到,而 AQP2-WT 则以非糖基化和复合糖基化形式观察到。与 AQP2-WT 相反,AQP2-L137P 突变体在用 forskolin 刺激后不会积聚在上皮细胞顶膜上。AQP2-L137P 的泛素化与 AQP2-WT 不同,具有各种分子量的非特征性蛋白带为主。与 AQP2-WT 相比,AQP2-L137P 突变体的半衰期缩短。用氯喹处理细胞会增加 AQP2-WT 的丰度,但不会增加 AQP2-L137P 的丰度。相比之下,用 MG132 处理会增加 AQP2-L137P 的丰度,但不会增加 AQP2-WT 的丰度。与 AQP2-L137P 相比,注射到非洲爪蟾卵母细胞中的 AQP2-WT 的渗透水通透性增加,这与该突变形式在质膜中缺失相关。从突变的定位和取代的性质来看,AQP2-L137P 可能导致蛋白质错误折叠,这可能是观察到的功能缺陷的原因。数据表明,L137P 突变导致 AQP2 蛋白成熟改变,通过蛋白酶体途径增加 AQP2 降解,并限制质膜表达。这些综合机制可能是导致此类 NDI 患者表型的原因。